PT
Protagenic Therapeutics, Inc.
PTIX · OTC
$0.79 -4.82% (-$0.04)
1M +125.71%
Market Cap $1.45M
P/E Ratio 0.27x
Div. Yield -
ROE -
Bulios Fair Price
$1.19
50.6% upside
Trenutna cena
$0.79
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PTIX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap P/E 0.27x
P/B 0.84x
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
21 /100
Poor ROIC 246.99%
ROA 261.82%
Asset turnover 0.00x
Debt
50 /100
Moderate Debt/Equity 0.00x
Current ratio 0.66x
Int. coverage -2.24x
Stability
29 /100
Unstable Beta 1.07x
EPS volatility 109.45%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PTIX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Garo H. Armen
Employees
2
Headquarters
New York
Prihajajoči dogodki
17 NOV.
Earnings
Upcoming earnings report